Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

iShares S&P 500 ETF

IVV

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

Commonwealth Bank of Australia

CBA

Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 51,346 full-time employees. Its segments include Retail Banking Services, Business Banking, Institutional Banking and Markets, New Zealand, and Corporate Center and Other. Retail Banking Services provides banking products and services to personal and private bank customers, helping them to manage their everyday banking needs, buy a home or invest in the future. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial services solutions. The company also provides equities trading and margin lending services through the CommSec business. Institutional Banking and Markets offers a full range of domestic and global financing and banking services to institutional and government clients. New Zealand includes the banking and funds management businesses operating in New Zealand under the ASB brand.

CSL Limited

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

OFX Group Limited

OFX

OFX Group Ltd. engages in providing international payment and foreign exchange services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2013-10-11. The company helps businesses and individuals to securely send and receive money, without bank fees. Its segments include APAC, North America and EMEA. Each region serves consumers, corporates, online sellers, and enterprise clients. The company provides simple payments to over 170+ countries online, in app, or over the phone with one of its OFXperts. Its Global Currency Account can make running clients' international or eCommerce business easier. Its eCommerce and business clients, the OFX Global Currency Account, allows clients to have up to seven foreign currency accounts, so they can pay invoices, receive payments, and easily reconcile transfers in euros, dollars or yen. An OFXpert will support and tailor solutions to clients' business needs. The company operates through various offices in London, Dublin, Sydney, Auckland, Hong Kong, Singapore, Toronto and San Francisco.